Pyxis Oncology Inc. (PYXS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.47
0.03 (2.08%)
At close: Jan 15, 2025, 3:59 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -0.97 | -0.38 | -4.34 | -35.49 | -169.94 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.57 | 0.28 | 1.35 | -28.95 | -157.58 |
P/FCF Ratio | -0.93 | -0.46 | -9.86 | -39.15 | -202.27 |
P/OCF Ratio | -1.02 | -0.5 | -10.01 | -44.91 | -202.27 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.17 | 0.12 | 0.00 | -0.05 | -0.01 |
Quick Ratio | 4.84 | 5.87 | 14.90 | 2.20 | 26.88 |
Current Ratio | 4.84 | 5.90 | 14.90 | 2.20 | 26.88 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.59 | -0.73 | -0.31 | 0.82 | 0.93 |
Return on Assets (ROA) | -0.42 | -0.56 | -0.29 | -1.26 | -0.13 |
Return on Capital (ROIC) | -0.56 | -0.69 | -0.27 | -2 | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |